Leidos Holdings Investing Cash Flow decreased by 7048.5% to -$2.36B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10622.7%, from -$22.00M to -$2.36B. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows an upward trend with a -13.7% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$244.00M | -$396.00M | -$53.00M | -$37.00M | -$21.00M | -$8.00M | -$26.00M | -$258.00M | -$39.00M | -$44.00M | -$52.00M | -$76.00M | -$12.00M | -$21.00M | -$23.00M | -$86.00M | -$22.00M | -$314.00M | -$36.00M | -$33.00M | -$2.36B |
| QoQ Change | — | -62.3% | +86.6% | +30.2% | +43.2% | +61.9% | -225.0% | -892.3% | +84.9% | -12.8% | -18.2% | -46.2% | +84.2% | -75.0% | -9.5% | -273.9% | +74.4% | <-999% | +88.5% | +8.3% | <-999% |
| YoY Change | — | — | — | — | +91.4% | +98.0% | +50.9% | -597.3% | -85.7% | -450.0% | -100.0% | +70.5% | +69.2% | +52.3% | +55.8% | -13.2% | -83.3% | <-999% | -56.5% | +61.6% | <-999% |